Current & Critical - David Harder, Paving the Way to Psychedelic-Assisted Therapy Through Education

Published: Dec. 20, 2022, 2:16 p.m.

As the Founder and CEO of ATMA Journey Centers, David Harder is at the forefront of a revolution in therapy and medicine happening right here in Alberta. With more professionals feeling comfortable discussing the power of psychedelic medicine, like psilocybin, ketamine, and MDMA, the need for education, training, and support for those working in this field has never been greater. In this episode, David shares how ATMA Journey Centers is rising to the challenge, providing education, training, and support for those working in the psychedelic medicine space. He also discusses the clinical trials underway at ATMA, which aim to see these powerful medicines approved by Health Canada for use in therapy.